Upgrade to SI Premium - Free Trial

Definium Therapeutics Inc (DFTX) PT Lowered to $58 at Canaccord

June 30, 2026 6:42 AM
(Updated - June 30, 2026 6:48 AM EDT)

Canaccord analyst Sumant Kulkarni lowered the price target on Definium Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change